Respiratory solutions provider VARON announced on Tuesday that it is expanding access to home oxygen concentrators.
The company said that this expansion is intended to help individuals with respiratory conditions maintain independence and an active lifestyle.
By providing flexible, user-friendly options, VARON ensures respiratory support is tailored to real-life needs, helping individuals breathe easier without limitations.
VARON offers a range of home and portable oxygen concentrators designed to fit different lifestyles. Its home oxygen concentrators are designed for long-term, stable oxygen support, while portable devices help users maintain active routines without sacrificing independence.
Roivant to announce Q3 2026 financial results
Avacta secures FDA clearance for second pre|CISION oncology programme
OncoHost receives BIG Innovation Award in Health category
Summit Therapeutics and GSK form collaboration to study ivonescimab combination therapy
Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer
Antin to acquire clinical trial equipment provider Emsere
Merck completes acquisition of Cidara Therapeutics for USD9.2bn
Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial
Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China
INOVIO's INO-3107 Biologics License Application accepted by US FDA
Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11
Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA